S&P Global Market Intelligence expands RiskGauge and Credit Analytics solutions coverage to 400 million corporate entities including U.S. private entities
Solution delivers a detailed picture of credit risk exposure for effective credit management
NEW YORK, March 3, 2025 /PRNewswire/ -- S&P Global Market Intelligence, a provider of information services and solutions to global markets, announced today the enhancement of its RiskGauge and Credit Analytics corporate entity coverage, expanding access to a database of over 400 million companies across more than 200 countries and territories, spanning all major sectors and industries. Powered by proprietary insights and analytics, the enhanced solution also offers configurable and downloadable credit risk assessment reports to provide a comprehensive picture of credit risk exposure.
'As companies face increasing pressures to understand and mitigate credit risk, these solutions deliver critical insights that help organizations navigate complex decisions,' said Whit McGraw, Head of Risk & Valuations Services, S&P Global Market Intelligence. 'This coverage expansion complements our real-time data and analytical capabilities, enabling our clients to make informed, strategic decisions as they navigate the complexities of the global marketplace.'
Key features include:
RiskGauge score, a combination of financial, business and market risk, for more than 400 million companies across 200+ countries and territories, major sectors and industries
Comprehensive up-to-date corporate information including company financials across developed and developing markets
Early Warning Framework for potential credit risk deterioration, and economic and geopolitical hot spots
Extensive workflow, data and analytics features for Non-Financial and Financial Corporates via Credit Analytics and RiskGauge Desktop platforms
RiskGauge reports with detailed historical performance, financials, firmographics and key developments
Data quality assurance via automated data audits and robust quality checks
For more information about RiskGauge, click here; for more information about Credit Analytics, click here.
About S&P Global Market Intelligence
At S&P Global Market Intelligence, we understand the importance of accurate, deep and insightful information. Our team of experts delivers unrivaled insights and leading data and technology solutions, partnering with customers to expand their perspective, operate with confidence, and make decisions with conviction.
S&P Global Market Intelligence is a division of S&P Global (NYSE: SPGI). S&P Global is the world's foremost provider of credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help many of the world's leading organizations navigate the economic landscape so they can plan for tomorrow, today. For more information, visit www.spglobal.com/marketintelligence.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures slip as investors assess easing trade tensions
US stock futures slipped as Wall Street assessed easing tensions between the US and key trading partners as well as softening inflation. Futures attached to the Dow Jones Industrial Average (YM=F) dipped 0.1%. Futures attached to the benchmark S&P 500 (ES=F) and the tech-heavy Nasdaq 100 (NQ=F) fell 0.2%. On Wednesday, Treasury Secretary Scott Bessent told Congress it is "highly likely" that countries engaging in trade negotiations with the US would see an extension of a tariff pause that is already in place on President Trump's most sweeping duties. Bessent's comment came after he returned from London on Tuesday, where representatives from US and China announced the countries had agreed to a proposal that would address critical trade disputes. Read more: The latest on Trump's tariffs Stocks wobbled during the day Wednesday amid the evolving trade news as well as the latest Consumer Price Index (CPI) report, which showed easing inflation pressures. The data puts the Federal Reserve in a tight spot ahead of its policy meeting next week, though analysts expect officials to maintain their wait-and-see approach to interest rate cuts as tariff uncertainty lingers. On Thursday, investors will receive fresh data on wholesale inflation with the release of the Producer Price Index (PPI) report. As earnings season wraps up, Adobe (ADBE) will also share its results. Sign in to access your portfolio
Yahoo
40 minutes ago
- Yahoo
Lunda Construction Awarded $67.2 Million I-94 and I-394 Interchange Project in Minneapolis
BLACK RIVER FALLS, Wis., June 11, 2025--(BUSINESS WIRE)--Tutor Perini Corporation (NYSE: TPC) (the "Company"), a leading civil, building and specialty construction company, announced today that its subsidiary, Lunda Construction Company, has been awarded a contract by the Minnesota Department of Transportation valued at approximately $67.2 million for the I-94 and I-394 Interchange Project in Minneapolis. The scope of work includes repairing 34 bridges and ramps along I-394 and I-94 between downtown Minneapolis and Highway 100. The project also includes maintenance work on the Dunwoody Boulevard ramp, replacing the deck for the Penn Avenue bridge that crosses over I-394, and other improvements along I-394 between downtown Minneapolis and Highway 100. Work is expected to begin in July 2025 with substantial completion anticipated in the summer of 2027. The contract value has been added to the Company's backlog in the second quarter of 2025. About Tutor Perini Corporation Tutor Perini Corporation is a leading civil, building and specialty construction company offering diversified general contracting and design-build services to private customers and public agencies throughout the world. We have provided construction services since 1894 and have established a strong reputation within our markets by executing large, complex projects on time and within budget while adhering to strict safety and quality control measures. We offer general contracting, pre-construction planning and comprehensive project management services, and have strong expertise in delivering design-bid-build, design-build, construction management, and public-private partnership (P3) projects. We often self-perform multiple project components, including earthwork, excavation, concrete forming and placement, steel erection, electrical, mechanical, plumbing, heating, ventilation and air conditioning (HVAC), and fire protection. View source version on Contacts Tutor Perini CorporationJorge Casado, 818-362-8391Senior Vice President, Investor Relations and Corporate Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
TransCon® hGH Boosts TransCon® CNP Results in Kids with Achondroplasia by Week 26
Ascendis Pharma A/S (NASDAQ:ASND) is among the 13 Biotech Stocks with Huge Upside Potential. It reported interim Week 26 data from its Phase 2 COACH Trial, confirming that combining TransCon hGH (lonapegsomatropin) with TransCon CNP (navepegritide) raised annualized growth velocity (AGV) and height Z-scores in children with achondroplasia. A close-up view of a hand manipulating a syringe while delivering TransCon CNP into a tumor. A mean AGV of 9.14 cm/year and a +0.53 Z-score rise were attained by treatment-naïve youngsters (N=12). Children (N=9) treated with TransCon CNP in the past achieved an AGV of 8.25 cm/year with a +0.44 Z-score improvement. The majority of side effects were modest, and safety remained consistent with monotherapies. The COACH Trial is the first to assess this combination in kids between the ages of two and eleven. While TransCon CNP is undergoing FDA priority review, TransCon hGH is approved as SKYTROFA® for juvenile growth hormone insufficiency. The treatment focuses on the FGFR3-CNP signaling imbalance that is at the heart of achondroplasia, a disorder that affects more than 250,000 people worldwide. It is anticipated that the results of week 52 and a scheduled Phase 3 trial in Q4 2025 will further clarify efficacy and long-term benefits. The biopharmaceutical business Ascendis Pharma A/S (NASDAQ:ASND) uses its TransCon technology platform to significantly improve patient outcomes. While we acknowledge the potential of ASND as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.